Podcasts about phytomedics inc

Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

Monday Night - Amad Painter - and Theresa J Morris will cover and Ira will be here Monday Night!  Chief Executive Officer, Bioquark Inc. Ira S. Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - a novel life sciences company focused on inducible, endogenous regeneration and cellular repair, to bring an end to many of the most devastating ailments associated with human disease, degeneration, and death - 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University. He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

Ira Pastor,  is the Chief Executive Officer of Bioquark Inc. He has over 30 years of experience across multiple sectors of the pharmaceutical industry.  These sectors include pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail.  Ira has served as VP, Business Development for drug development company Phytomedics Inc.  Ira spearheaded raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.  Prior to that, Ira was employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance).  He earned his MBA from Temple University and his BS, Pharmacy from Rutgers University. In addition, Ira is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/.) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions.  He also serves on the Reanima Project (http://www.reanima.tech),and is a member of the World E.conomic Forum’s  Human Enhancement council (https://www.weforum.org/people/ira-pastor). Ira Pastor - Pharmacist to Entrepreneur Ira grew up in the Philadelphia area and was a pharmacist by training.  He then pursued a degree in business. Ira’s entrepreneur training dates back to his father, a naval shipman in WW2.  His father was also a pharmacist by trade and built a successful community pharmacy.  At an early age, Ira saw his father’s determination and work ethic during the depression.  Additionally, his dad’s military background was an important factor for instilling these characteristics. Passion of Regenerating, Repairing and Healing As Ira grew up in the family pharmacy business, he knew early on that he would be a pharmacist.  He worked side by side with his father and eventually evolved to the next phase-big biotech questions.  Ira was missing the entrepreneurial spirited angle and needed something more tangible so he jumped into a smaller biotech.  Bioquark and 3 R’s. Regeneration Repair Rejuvenation “How we can do a better job of regenerating, repairing and healing people; veterans fall in a major way in that category from some of the most traumatic, chronic and acute damage that are experienced.” – Ira Pastor Bioquark’s Mission “How we can move as an industry to addressing these much bigger problems associated with human degeneration, deterioration and death?”- Ira Pastor Don’t forget to leave us a 5-star rating and review if you enjoyed the show. We would love to hear from you! Check out these links for Ira Pastor Bioquark Webiste Join the Veteran on the Move on Facebook! Check out Veteran on the Move on Facebook to connect with our guests! It’s a great place where you can stay in touch with other veterans who are transitioning to entrepreneurship.  Get updates and free gouge on the people, programs and resources to help you in your transition to entrepreneurship. Veteran On the Move podcast has published over 200 episodes. Our listeners have the opportunity to hear in-depth interviews conducted by host Joe Crane . The podcast features people, programs and resources to assist veterans in their transition to entrepreneurship.  As a result, Veteran On the Move has over 1,000,000 verified downloads through Stitcher Radio, Sound Cloud, itunes and RSS Feed Syndication making it one of the most popular Military Entrepreneur Shows on the Internet Today.

 Regenerative Biology - Cellular Combinatorial BiologicsIra Pastor - CEO – http://www.bioquark.com (Bioquark Inc). The biologic regulatory states of our cells, tissues, and organs represent the central control processes behind our health (as well as our unfortunate transition towards disease, degeneration, and aging). His work at Bioquark focuses on these critical biomedical issues. Merging 21st-century knowledge of regenerative biology, evolutionary genomics, and bio-cybernetics, Bioquark's core program focuses on developing a novel class of substances termed combinatorial biologics, which take a unique approach to reversing underlying disease, degeneration or aging processes, as opposed to only affecting the symptoms of such conditions. His Brief Bio: "Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions." * Photo:Marco-Secchi-549646-unsplash His Perspective & Background"We currently live on a planet with other organisms that from a health and wellness perspective, are much further advanced than human beings. Many lower organisms can replace lost or damaged organs and tissues that are identical in structure and function to the original, effortlessly regenerating a wide variety of living tissues, including spinal cords, limbs, hearts, eyes, and even parts of their brains. Similarly, many of these same species possess fascinating skills for repairing and reversing the cellular and genetic damage. Cancer, as an example, is found to be extremely rare in species displaying an efficient regenerative mechanism, even under the action of potent carcinogens. In many cases, when cancer does occur, tumors have been found to remodel and integrate into their surroundings spontaneously, as healthy tissue. Some of these organisms can age, and then return to a youthful state later on in life. Some can even die and be reborn." Join us the hear about the varieties of http://corebrainjournal.com/testing (compelling searches for new healing options). Referenced Detailshttp://onlinelibrary.wiley.com/doi/10.1111/j.1440-169X.2007.00914.x/pdf (http://onlinelibrary.wiley.com/doi/10.1111/j.1440-169X.2007.00914.x/pdf) http://onlinelibrary.wiley.com/doi/10.1002/dneu.20918/pdf (http://onlinelibrary.wiley.com/doi/10.1002/dneu.20918/pdf) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706275/ (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706275/) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC433040/ (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC433040/) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC335936/ (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC335936/) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1735296/pdf/v040p00721.pdf (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1735296/pdf/v040p00721.pdf) http://jcb.rupress.org/content/200/6/689.full (http://jcb.rupress.org/content/200/6/689.full) http://precedings.nature.com/documents/6045/version/1/files/npre20116045-1.pdf (http://precedings.nature.com/documents/6045/version/1/files/npre20116045-1.pdf) http://jcb.rupress.org/content/115/6/1479.long (http://jcb.rupress.org/content/115/6/1479.long) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2113692/pdf/jc1012518.pdf (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2113692/pdf/jc1012518.pdf) http://jcs.biologists.org/content/95/3/383.full.pdf (http://jcs.biologists.org/content/95/3/383.full.pdf) -----------Pastor's Connectionshttp://bioquark.com (bioquark.com) --------------- Forward This Audio Message Link To

Join host Amy Zellmer as she speaks with Ira Pastor. Ira Pastor - Chief Executive Officer – Bioquark Inc. (www.bioquark.com) - Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University; He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor). sponsored by: Minnesota Functional Neurology, DC

Ira has over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialisation, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Ira has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); He has an MBA, Temple University and a BS, Pharmacy, Rutgers University. He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).He runs Bioquark, which is focused on the development and commercialisation of a novel range of biologic based products and services that have the ability to alter the biological regulatory state of human tissues and organs, with the goal of curing a wide range of diseases.Web: http://bioquark.com LinkedIn: https://www.linkedin.com/in/iraspastorTwitter: https://twitter.com/irat1onal Facebook company page: https://www.facebook.com/Bioquark Facebook profile: https://www.facebook.com/ira.pastor.7

Bioquark Inc. & Tissue Regeneration with Ira S. Pastor Bioquark Inc. is focused on the development of novel biologics that have the ability to naturally modify the regulatory state of human tissues and organs, with the goal of curing a range of chronic degenerative diseases, as well as effecting complex regeneration. The biologic regulatory states of our cells, tissues, and organs represent the central control processes behind our health (as well as our unfortunate transition towards disease, degeneration, and aging). Merging 21st-century knowledge of regenerative biology, evolutionary genomics, and bio-cybernetics, Bioquark’s core program focuses on developing a novel class of substances termed combinatorial biologics, which take a unique approach to reversing underlying disease, degeneration or aging processes, as opposed to only affecting the symptoms of such conditions. Ira Pastor, Chief Executive Officer More than 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development. For more information visit: http://www.bioquark.com/ ************************************************* For more information about BITEradio products and services visit: http://www.biteradio.me/index.htm

ASK A SCIENTIST @ IRA PASTOR Ira Pastor – Chief Executive Officer. Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc.  BioQuark's Ira Pastor: Meet the Man Whose Biotech Company Is https://nextshark.com/ira-pastor-bioquark-interview/ May 5, 2016 - Meet Ira Pastor, the CEO of BioQuark, director of the ReAnima project, and a man who may soon bring the dead back to life. In the coming months, Pastor's team of doctors will attempt to bring patients back from what science considers to be an irreversible death.

Fernando Aires guest hosts this edition of the Holistic Survival Show, and talks with Ira Pastor, CEO of Bioquark. He's been in the pharmaceutical industry for 30+ years in a wide variety of positions. Before joining Bioquark, Ira served as VP of Business Development for the Phytomedics Inc., bringing in $40 million of private equity and over $50 million of licensing deals. Ira and Fernando discuss Bioquark's current investigation into making our bodies regenerate like other organisms, in order to avoid all the trouble that can be created by introducing foreign bodies into our ecosystem. Key Takeaways: [2:32] How Bioquark works [4:38] Why humans aren't able to regenerate parts like "lower" organisms [9:59] What triggers in the body cause regeneration to start? [12:38] If Bioquark is tapping into our youthful regeneration to make our bodies heal faster [16:57] The types of problems Bioquark is designed to solve [20:36] How is it possible to bring people back from the dead? [24:11] If they are currently doing any clinical research for recovering braindead patients [28:49] Where the money for their research and development is coming from [29:15] The biggest challenges facing Bioquark's work Website: www.bioquark.com www.reanima.tech www.regenerage.clinic

Ira Pastor - Chief Executive Officer – Bioquark Inc. - 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Mr. Pastor has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); MBA, Temple University; BS, Pharmacy, Rutgers University More information about the ReAnima Project can be found here.